tiprankstipranks
Advertisement
Advertisement
Wolfe Research says Compass Pathways pullback an attractive entry point
PremiumThe FlyWolfe Research says Compass Pathways pullback an attractive entry point
4d ago
Analyst Reaffirms Buy on CMPS, Viewing Post-Data Pullback as Entry Opportunity Ahead of 1H27 Launch
Premium
Ratings
Analyst Reaffirms Buy on CMPS, Viewing Post-Data Pullback as Entry Opportunity Ahead of 1H27 Launch
4d ago
Compass Pathways announces six-month data from COMP006 trial
Premium
The Fly
Compass Pathways announces six-month data from COMP006 trial
4d ago
Psychedelic: Helus Pharma reports FY26 financial results
PremiumThe FlyPsychedelic: Helus Pharma reports FY26 financial results
9d ago
Compass Pathways price target raised to $20 from $18 at Canaccord
Premium
The Fly
Compass Pathways price target raised to $20 from $18 at Canaccord
15d ago
COMPASS Pathways PLC put volume heavy and directionally bearish
Premium
The Fly
COMPASS Pathways PLC put volume heavy and directionally bearish
17d ago
COMPASS Pathways Shareholders Approve 2026 AGM Proposals, Board Changes
PremiumCompany AnnouncementsCOMPASS Pathways Shareholders Approve 2026 AGM Proposals, Board Changes
1M ago
Psychedelic: Enveric, NRx, Bright Minds report quarterly earnings
Premium
The Fly
Psychedelic: Enveric, NRx, Bright Minds report quarterly earnings
2M ago
Compass Pathways price target raised to $20 from $12 at Maxim
Premium
The Fly
Compass Pathways price target raised to $20 from $12 at Maxim
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100